Siblings 會議論文/會議摘要 [41/48] 報告 [0/1] 專利 [0/11] Collection Statistics 近3年內發表的文件:0(0.00%) 含全文筆數:193(99.48%) 文件下載次數統計 下載大於0次:193(100.00%) 下載大於100次:193(100.00%) 檔案下載總次數:122368(83.64%) 最後更新時間: 2024-11-28 13:17 Top Upload Loading... Top Download Loading... Recent Submissions Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 194. (20 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-16	Identification of prognostic biomarkers originating from the tumor stroma of betel quid-associated oral cancer tissues	Frontiers in Oncology. 2021 Nov 16;11:Article number 769665.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-01-12	Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells	Scientific Reports. 2021 Jan 12;11:Article number 644.
2020-08	The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells	Toxicology and Applied Pharmacology. 2020 Aug;401:Article number 115080.
2020-07-17	Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer[Erratum:Scientific Reports. 2019 Mar;9:Article number 3931.]	Scientific Reports. 2020 Jul 17;10:Article number 12216.
2020-06-28	Index of cancer-associated fibroblasts is superior to the epithelial–mesenchymal transition score in prognosis prediction	Cancers. 2020 Jun 28;12(7):Article number 1718.
2020-06	Pharmacological inhibition of cathepsin S suppresses abdominal aortic aneurysm in mice	European Journal of Vascular and Endovascular Surgery. 2020 Jun;59(6):990-999.

Showing items 1-10 of 194. (20 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page